Type of hormone therapy and risk of misclassification at mammography screening

Research output: Contribution to journalJournal articleResearchpeer-review

Sisse H Njor, Jesper Hallas, Walter Schwartz, Elsebeth Lynge, Anette Tønnes Pedersen

Current users of hormone therapy (HT) are known to have a lower accuracy of mammography screening than do never users. We studied whether the risk of misclassification depends on type of hormone, administration, regimen, and dose of the therapy.
Original languageEnglish
JournalMenopause
Volume18
Issue number2
Pages (from-to)171-177
Number of pages7
ISSN1072-3714
DOIs
Publication statusPublished - 1 Feb 2011

    Research areas

  • Aged, Breast Neoplasms, Carcinoma, Denmark, Diagnostic Errors, Early Detection of Cancer, Female, Hormone Replacement Therapy, Humans, Mammography, Mass Screening, Middle Aged, Risk, Treatment Outcome

ID: 34117796